Koskensalo, Kalle
Virtanen, Sami
Saunavaara, Jani
Parkkola, Riitta
Laitio, Ruut
Arola, Olli
Hynninen, Marja
Silvasti, Päivi
Nukarinen, Eija
Martola, Juha
Silvennoinen, Heli M.
Tiainen, Marjaana
Roine, Risto O.
Scheinin, Harry
Saraste, Antti
Maze, Mervyn
Vahlberg, Tero
Laitio, Timo T. http://orcid.org/0000-0002-2617-9358
,
Funding for this research was provided by:
State Research Funding, Finland
Sydäntutkimussäätiö
Academy of Finland
University of Turku (UTU) including Turku University Central Hospital
Article History
Received: 2 May 2022
Accepted: 3 October 2022
First Online: 17 October 2022
Declarations
:
: The study was approved by the ethics committee of the Hospital District of Southwest Finland and the institutional review boards of the Helsinki University Hospital and the Finnish Medicines Agency.
: All patients’ next of kin or legal representative gave written informed assent within 4 h after hospital arrival. Consent was sought from patients when they regained consciousness.
: Not applicable.
: TL reports a grant from the Finnish Foundation for Cardiovascular Research. RL is a paid governmental consultant official for the National Supervisory Authority for Welfare and Health. AS reports grants from the Academy of Finland and Finnish Foundation for Cardiovascular Research during the conduct of the study; consulting fees from the GE Healthcare, Novartis, Abbot, and Astra Zeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.